Blood might carry an untapped source of biomarkers

Nov 02, 2010

Researchers have uncovered a potential source of blood-derived biomarkers for certain kinds of cancer, according to a study.

Cancer diagnosis based on the detection of cancer-related proteins in blood sometimes fails because the proteins are short-lived or hard to detect.

Arie Admon and colleagues have found that peptide fragments derived from the cancer-related proteins attached to immune molecules - called human leukocyte antigens, or HLA - could be used as a potential source of biomarkers in people with cancers such as multiple myeloma and leukemia.

The HLA molecules help ferry fragments of degraded proteins from the cytoplasm of cancer cells to the cell surface, where the HLA-peptide complexes are presented for inspection by . Whereas normal cells secrete small amounts of HLA-peptide complexes into the blood, often secrete larger amounts.

The authors used biochemical methods to detect thousands of HLA-peptide complexes in the patients' blood plasma; many of those complexes were derived from cancer-related proteins.

Further, the authors found similar HLA-peptide profiles for the same individual when blood was collected and analyzed on different days. Because HLA-peptide complexes can be rapidly isolated from blood, the could serve as a potential source of clinically useful cancer biomarkers if the findings are validated in large numbers of patients and healthy controls, according to the authors.

Explore further: Stem cells faulty in Duchenne muscular dystrophy

More information: "The soluble plasma HLA peptidome as a potential source for cancer biomarkers," by Michal Bassani-Sternberg et al. Proceedings of the National Academy of Sciences.

Provided by Proceedings of the National Academy of Sciences

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Modeling pathogen responses

Oct 12, 2007

The search for a vaccination against HIV has been in progress since 1984, with very little success. Traditional methods used for identifying potential cellular targets can be very costly and time-consuming. The key to creating ...

New biomarkers for predicting the spread of colon cancer

Jan 13, 2010

Scientists in China are reporting discovery of two proteins present in the blood, of people with colon cancer that may serve as the potential biomarkers for accurately predicting whether the disease will spread. ...

Recommended for you

Stem cells faulty in Duchenne muscular dystrophy

7 hours ago

Like human patients, mice with a form of Duchenne muscular dystrophy undergo progressive muscle degeneration and accumulate connective tissue as they age. Now, researchers at the Stanford University School of Medicine have ...

Here's how the prion protein protects us

12 hours ago

The cellular prion protein (PrPC) has the ability to protect the brain's neurons. Although scientists have known about this protective physiological function for some time, they were lacking detailed knowledge ...

Regulation of maternal miRNAs in early embryos revealed

13 hours ago

The Center for RNA Research at the Institute for Basic Science (IBS) has succeeded in revealing, for the first time, the mechanism of how miRNAs, which control gene expression, are regulated in the early embryonic stage.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.